Cart
sales@molnova.com
TAE-1
CAS No. 1414469-59-2
TAE-1( —— )
Catalog No. M23568 CAS No. 1414469-59-2
TAE-1 is an inhibitor of amyloid-β fibril formation and aggregation. It inhibits cholinesterases AChE and BuChE with IC50 of 0.3 μM and 3.9 μM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 35 | In Stock |
|
| 25MG | 80 | In Stock |
|
| 50MG | 140 | In Stock |
|
| 100MG | 205 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTAE-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTAE-1 is an inhibitor of amyloid-β fibril formation and aggregation. It inhibits cholinesterases AChE and BuChE with IC50 of 0.3 μM and 3.9 μM, respectively.
-
DescriptionTAE-1 is an inhibitor of amyloid-β fibril formation and aggregation. It inhibits cholinesterases AChE and BuChE with IC50 of 0.3 μM and 3.9 μM, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorAChE|amyloid-β
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1414469-59-2
-
Formula Weight1128.57
-
Molecular FormulaC39H51I3N6O9
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC[N+](C)(C)CCOC(=O)C1=CC=C(C=C1)OC2=NC(=NC(=N2)OC3=CC=C(C=C3)C(=O)OCC[N+](C)(C)C)OC4=CC=C(C=C4)C(=O)OCC[N+](C)(C)C.[I-].[I-].[I-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Biological activity of sym-triazines with acetylcholine-like substitutions as multitarget modulators of Alzheimer's disease.[J]. Acs Chemical Neuroscience, 2013, 4(6):924-9.
molnova catalog
related products
-
Ipratropium Bromide
Ipratropium Bromide is an antagonist of M3 type muscarinic acetylcholine receptors, used for the treatment of chronic obstructive pulmonary disease (COPD).
-
Sitogluside
Eleutheroside A (Daucosterol) has proliferation-enhancing activity, may be involved in the IGF1-AKT pathway.
-
Varenicline
Varenicline is a Selective α4β2 nicotinic acetylcholine receptor partial agonist.
